Kaiser Permanente has helped the parent company of in vitro diagnostics test provider ET Healthcare and biotechnology developer Gator Bio close its latest round.

Lilly Asia Ventures was among the investors in a series B round for the renal disease treatment developer, which it incubated in 2018.

The genome sequencing technology provider has boosted its total funding to approximately $124m, Sinopharm and China General Technology Group having backed a $38.7m round.

China Life Healthcare Fund and Venus Medtech have taken part in a round for the heart valve treatment developer sized in the hundreds of millions of dollars.

Tekfen Ventures, Cisco Investments and Qualcomm Ventures are set to exit the crop monitoring technology developer later this year in a deal with Valmont Industries.

Bitmain and DRW subsidiary Cumberland Mining are set to exit the crypto finance software provider five years after their investment.

Opioid addiction care provider Groups Recover Together and healthcare management platform developer Vim each raised $60m, with Optum Ventures backing both rounds.

Le Groupe Bel, AAK, Meiji, Bühler and Tyson Foods all contributed to the firm's debut fund, which is targeting plant-based food developers.

SAP and Publicis Sapient have selected seven participants for the Israel branch of the former's SAP Foundries initiative.